Galapagos shows that the fittest can survive Interviewee/Contributor Piet Wigerinck and Walid Abi-Saab Organisation Galapagos NV Drug discovery Strategy Read more about Galapagos shows that the fittest can survive
Risk sharing with Pharma -- is this the way to go? Interviewee/Contributor Onno van de Stolpe Organisation Galapagos NV Strategy Pharma Drug discovery Read more about Risk sharing with Pharma -- is this the way to go?
How Galapagos built a business from discovery Interviewee/Contributor Onno van de Stolpe Organisation Galapagos NV Strategy Drug discovery Read more about How Galapagos built a business from discovery
How Galapagos built a business from discovery Interviewee/Contributor Onno van de Stolpe Organisation Galapagos NV Target discovery Rheumatoid arthritis Osteoarthritis Adenoviris Read more about How Galapagos built a business from discovery